Page last updated: 2024-08-21

butyramide and Cardiotoxicity

butyramide has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abete, P; Aitoro, R; Avagliano, C; Berni Canani, R; Bianco, R; Bonaduce, D; Calignano, A; Ciccarelli, M; Fiordelisi, A; Ghigo, A; Guida, F; Hirsch, E; Iaccarino, G; Li, M; Mercurio, V; Napolitano, F; Paparo, L; Russo, M; Sala, V; Sorriento, D; Tocchetti, CG; Trinchese, G	1

Other Studies

1 other study(ies) available for butyramide and Cardiotoxicity

Article	Year
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity. European journal of heart failure, 2019, Volume: 21, Issue:4 Topics: Amides; Animals; Antibiotics, Antineoplastic; Apoptosis; Butyrates; Butyric Acid; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Echocardiography; Mice; Mice, Inbred C57BL; Mitochondria; Myocytes, Cardiac; Oxidative Stress; Phenylalanine; Protective Agents; Treatment Outcome	2019

Article

Year

The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.

European journal of heart failure, 2019, Volume: 21, Issue:4

Topics: Amides; Animals; Antibiotics, Antineoplastic; Apoptosis; Butyrates; Butyric Acid; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Echocardiography; Mice; Mice, Inbred C57BL; Mitochondria; Myocytes, Cardiac; Oxidative Stress; Phenylalanine; Protective Agents; Treatment Outcome

2019